Anti-microbial resistance ‘missing in action’ from corporate disclosure frameworks

UK investment heavyweights LGIM and Aviva push for the inclusion of AMR in the ISSB and green taxonomies.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.